Back to BlackRock, Inc. BlackRock, Inc.

ACRSACRS
7 quarters

Position history for BlackRock, Inc.BlackRock, Inc.'s holdings in ACLARIS THERAPEUTICS INC

BlackRock, Inc. holds 10M shares of ACRS (ACLARIS THERAPEUTICS INC), worth $53.1M as of 2026-Q2. The position was increased (+35.5% shares). ACRS represents 0.0% of BlackRock, Inc.'s portfolio.

Current Value

$53.1M

Current Shares

10M

Total Value Change

+$50M

Total Shares Change

+8.8M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
10M
+35.5%
$53.1M0.0%$5.29
38
2026-Q1
Increased
7.4M
+8.8%
$27.8M0.0%$3.04
31
2025-Q4
Increased
6.8M
+19.6%
$20.5M0.0%$2.90
34
2025-Q3
Increased
5.7M
+3.2%
$10.8M0.0%$1.92
29
2025-Q2
Increased
5.5M
+305.2%
$7.8M0.0%$1.47
44
2025-Q1
Increased
1.4M
+8.2%
$2.1M0.0%$1.59
19
2024-Q4
New
1.3M
-
$3.1M0.0%$2.48
37

Other major holders of ACRS: BNP PARIBAS FINANCIAL MARKETS, WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used